The Uttar Pradesh government on Thursday announced that Phase-III trials of the coronavirus (COVID-19) vaccine ‘COVAXIN‘ will start in Lucknow and Gorakhpur from October.
“The phase-3 trial of COVAXIN being developed by Bharat Biotech will start in Lucknow and Gorakhpur from October,” said Uttar Pradesh Principal Health Secretary Amit Mohan Prasad in a press conference.
The Indian Council for Medical Research (ICMR) is collaborating with Bharat Biotech for the development of the COVAXIN.
Meanwhile, Congress leader Deepak Singh on Thursday wrote a letter to Chief Minister Yogi Adityanath and requested to increase testing for COVID-19 in Uttar Pradesh.
According to the Union Health Ministry as of Thursday, there are 61,698 active cases in the state with 3,02,689 recovered people and 5,299 deaths.
Bharat Biotech announces licensing agreement with Washington Univ